Nadia Bouabdallaoui

Nadia Bouabdallaoui

Auto-generated profile, based on publicly available information

Nadia Bouabdallaoui

Centre Hospitalier de L’Université de Montreal and Université de Montreal, Montreal, Canada

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2020 in European Heart Journal
Verified
Journal Article
Open access
PDF file
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
Jean-Claude TardifJean-Claude Tardif
Jean-Claude Tardif
DWDavid D Waters
David D Waters
FPFAUSTO J PINTO
FAUSTO J PINTO
Aldo Pietro MaggioniAldo Pietro Maggioni
Aldo Pietro Maggioni
FRFrançois Roubille
François Roubille
The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the benefits of targeting inflammation after myocardial infarction (MI). We aimed to determine whether time-to-treatment initiation (TTI) influences the beneficial impact of colchicine. In COLCOT, patients were randomly assigned to receive colchicine or placebo within 30 days post-MI. Time-to-treatment initiation was defined as the length of time between the index MI and the initiation of study medication. The primary efficacy endpoint was a composite of cardiovascular death, resuscitated cardiac arrest, MI, stroke, or urgent hospitalization for angina requiring coronary revascularization. The relationship between endpoints and various TTI (<3, 4–7 and >8 days) was examined using multivariable Cox regression models. Amongst the 4661 patients included in this analysis, there were 1193, 720, and 2748 patients, respectively, in the three TTI strata. After a median follow-up of 22.7 months, there was a significant reduction in the incidence of the primary endpoint for patients in whom colchicine was initiated < Day 3 compared with placebo [hazard ratios (HR) = 0.52, 95% confidence intervals (CI) 0.32–0.84], in contrast to patients in whom colchicine was initiated between Days 4 and 7 (HR = 0.96, 95% CI 0.53–1.75) or > Day 8 (HR = 0.82, 95% CI 0.61–1.11). The beneficial effects of early initiation of colchicine were also demonstrated for urgent hospitalization for angina requiring revascularization (HR = 0.35), all coronary revascularization (HR = 0.63), and the composite of cardiovascular death, resuscitated cardiac arrest, MI, or stroke (HR = 0.55, all P < 0.05). Patients benefit from early, in-hospital initiation of colchicine after MI. COLCOT ClinicalTrials.gov number, NCT02551094.

2 October 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
WBWilliam Beaubien‐Souligny
William Beaubien‐Souligny
ABAymen Benkreira
Aymen Benkreira
PRPierre Robillard
Pierre Robillard
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
MCMichaël Chassé
Michaël Chassé
ADAndré Denault
André Denault
Background: Acute kidney injury ( AKI ) after cardiac surgery is associated with adverse outcomes. Venous congestion can impair kidney function, but few tools are available to assess its impact at the bedside. The objective of this study was to determine whether portal flow pulsatility and alterations in intrarenal venous flow assessed by Point‐Of‐Care ultrasound are associated with AKI after cardiac surgery. Methods and Results: This single‐center prospective cohort study recruited patients undergoing cardiac surgery with cardiopulmonary bypass. Hepatic and renal Doppler ultrasound assessments were performed before surgery, at the intensive care unit admission, and daily for 3 days after surgery. The primary statistical analysis was performed using proportional hazards model for time‐dependent variables. Among the 145 patients included, 49 patients (33.8%) developed AKI after cardiac surgery. The detection of portal flow pulsatility was associated with an increased risk of AKI (hazard ratio: 2.09, confidence interval, 1.11–3.94, P=0.02), as were severe alterations of intrarenal venous flow (hazard ratio: 2.81, confidence interval, 1.42–5.56, P =0.003). These associations remained significant in multivariable models. The addition of these markers to preoperative risk factors and central venous pressure measurement at intensive care unit admission improved the prediction of AKI . (Continuous net reclassification improvement: 0.364, confidence interval, 0.081–0.652 for portal Doppler and net reclassification improvement: 0.343, confidence interval, 0.081–0.628 for intrarenal Doppler) Conclusions: Portal flow pulsatility and intrarenal flow alterations are markers of venous congestion and are independently associated with AKI after cardiac surgery. These tools might offer valuable information to develop strategies aimed at treating or preventing congestive cardiorenal syndrome after cardiac surgery. Clinical Trial Registration: URL : https://www.clinicaltrials.gov . Unique identifier: NCT 02831907.

1 January 2016 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
SMSylvestre Maréchaux
Sylvestre Maréchaux
RSRohan Samson
Rohan Samson
EBEric van Belle
Eric van Belle
JBJoke Breyne
Joke Breyne
JMJuliette de Monte
Juliette de Monte
PEPierre-Vladimir Ennezat
Pierre-Vladimir Ennezat

11 September 2018 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
BCBrian Claggett
Brian Claggett
MZMichael R. Zile
Michael R. Zile
JMJohn J.V. McMurray
John J.V. McMurray
EOEileen O'Meara
Eileen O'Meara
FCfor the PARADIGM‐HF Investigators and Committees
for the PARADIGM‐HF Investigators and Committees

1 November 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
IEIsmail El-Hamamsy
Ismail El-Hamamsy
MPMagali Pham
Magali Pham
GGGenevieve Giraldeau
Genevieve Giraldeau
MPMarie-Claude Parent
Marie-Claude Parent
ADAnique Ducharme
Anique Ducharme

19 July 2008 in European Radiology
Verified
Journal Article
Closed access
PDF file
FMFrederic Mouquet
Frederic Mouquet
CLChristophe Lions
Christophe Lions
PGPascal de Groote
Pascal de Groote
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
SWSerge Willoteaux
Serge Willoteaux
JBJean Paul Beregi
Jean Paul Beregi